Zinc stable isotopes in urine as diagnostic for cancer of secretory organs

Abstract

Breast, prostatic and pancreatic cancers alter the zinc (Zn) metabolism. Combined analyses of urinary Zn concentrations ([Zn]) and Zn stable isotope compositions (δ66Zn) may provide a non-invasive approach for tracing malignancy-induced Zn dyshomeostasis. In this study, we measured [Zn] and δ66Zn in urine from prostate (n = 22), breast (n = 16) and from women with benign breast disease (n = 14) and compared those to age-matched healthy controls (22–49 yrs or 50 + yrs) and published data for pancreatic cancer (n = 17). Our results show cancer-induced changes are reflected in higher urinary [Zn] and lower urinary δ66Zn for pancreatic and prostate cancer and benign breast disease when compared to healthy controls. For prostate cancer, low [Zn] and high δ66Zn for patients of low-risk disease progresses towards high [Zn] and low δ66Zn for the higher-risk patients, demonstrates that [Zn] and δ66Zn in urine could serve as a reliable prognostic tool. Urinary excretion of isotopically light Zn by patients with prostatic and pancreatic cancer is probably the result of increased reactive oxygen species in cancerous cells, which limits the scavenging of hydroxyl radicals and thus facilitates the oxidation of metalloproteins with sulfur-rich ligands. Urine from malignant breast cancer patients shows undistinguishable δ66Zn to healthy controls, implying that the expression of metalloproteins with sulfur-rich ligands is stronger in breast cancer tissues. In conclusion, urinary δ66Zn may provide a non-invasive diagnostic tool for pancreatic cancer and support disease prognosis for prostate cancer. These findings should translate to comprehensive transverse and longitudinal cohort studies in future.

Iron Isotopic Composition of Biological Standards Relevant to Medical and Biological Applications

“…Major recent advances include the potential early diagnosis of osteoporosis from the Ca isotope composition of blood and urine ( 11 ), and the potential detection of Alzheimer's disease markers traced by the Cu isotope composition of the serum ( 21 , 28 ). Moreover, significant differences between healthy patients and cancer patients blood samples have been detected for S and Cu isotopes and for several types of cancers ( 7 , 26 ), suggesting that the study of metal isotope fractionation could be used for diagnosis as well as investigation of metabolic processes associated to cancer ( 29 , 30 ). Among these elements, Fe plays a central role as it corresponds to the most abundant metal in the human body and has a turnover time of several years ( 31 , 32 ).…”

Zinc in Prostate Health and Disease: A Mini Review

“…Recent studies with other cancers indicate that Zn-induced changes can be detected through the ratios of the stable isotopes of Zn (Zn 64 and Zn 66 ) in urine and plasma [ 202 , 203 , 204 ]. The theory behind these findings is that in the event of cancer, the heavier isotope Zn 66 is retained in the tissue over the release of the lighter isotope.…”

Study of the Protective Role of Zn in Cultured Retinal Pigment Epithelial Cells Subjected to Pro-Inflammatory Conditions Using Transcriptomics and Mass Spectrometry

“…Breast cancer tumour tissue displays a lighter Zn isotopic composition than that of the blood, serum and healthy breast tissue [22]. Also the urine Zn isotopic composition of patients suffering from pancreatic or prostate cancer or from benign breast disease was lighter than that of healthy subjects [23].…”